Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Angioletta Lasagna
Observed names:
A Lasagna,
A. Lasagna,
Lasagna, Angioletta
Institution:
Policlinico San Matteo Fondazione
Observed institutions:
University of Pavia,
Policlinico San Matteo Fondazione,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0002-9611-1164
Observed ORCID:
0000-0002-9611-1164
OpenAlex ID:
A5031988137
Early 7-day supplemental parenteral nutrition improves body composition and muscle strength in hypophagic cancer patients at nutritional risk
2018
·
Riccardo Caccialanza
, Emanuele Cereda
, et al.
·
Supportive Care in Cancer
·
56
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study
2025
·
L. Provenzano
, M.V. Dieci
, et al.
·
Annals of Oncology
·
54
PDF
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
2020
·
Marco Lucioni
, Chiara Rossi
, et al.
·
European Radiology
·
53
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study
2023
·
Erika Asperges
, Giuseppe Albi
, et al.
·
Infectious Diseases and Therapy
·
51
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study
2021
·
A. Lasagna
, F. Agustoni
, et al.
·
ESMO Open
·
46
PDF
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center
2019
·
Carlos A. Garcia-Etienne
, Alberta Ferrari
, et al.
·
European Journal of Surgical Oncology
·
38
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM)
2022
·
P. Pedrazzoli
, A. Lasagna
, et al.
·
ESMO Open
·
36
PDF
Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature
2023
·
Chiara Rossi
, Sara Fraticelli
, et al.
·
Breast Cancer Research and Treatment
·
32
PDF
Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review
2024
·
Salvatore Corallo
, Angioletta Lasagna
, et al.
·
Pathogens
·
31
PDF
Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy
2023
·
Angioletta Lasagna
, Federica Mascaro
, et al.
·
Cancer Medicine
·
27
PDF
The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study
2022
·
Angioletta Lasagna
, Mara De Amici
, et al.
·
Pathogens
·
27
PDF
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems
2024
·
Flavia Jacobs
, Saverio D’Amico
, et al.
·
Digital Health
·
26
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
2023
·
P. Pedrazzoli
, A. Lasagna
, et al.
·
ESMO Open
·
24
PDF
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
2021
·
A. Lasagna
, D. Lilleri
, et al.
·
ESMO Open
·
24
PDF
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
2022
·
A. Lasagna
, F. Bergami
, et al.
·
ESMO Open
·
22
Early 7-day supplemental parenteral nutrition improves body composition and muscle strength in hypophagic cancer patients at nutritional risk
2018
·
R. Caccialanza
, E. Cereda
, et al.
·
Clinical Nutrition
·
22
Development of Hepatitis Triggered by SARS-CoV-2 Vaccination in Patient with Cancer During Immunotherapy: A Case Report
2022
·
Angioletta Lasagna
, Marco Vincenzo Lenti
, et al.
·
Immunotherapy
·
20
PDF
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern
2022
·
A. Lasagna
, F. Bergami
, et al.
·
ESMO Open
·
19
PDF
COVID-19 and breast cancer: may the microbiome be the issue?
2020
·
Angioletta Lasagna
, Valentina Zuccaro
, et al.
·
Future Oncology
·
19
PDF
The ABC of Immune-Mediated Hepatitis during Immunotherapy in Patients with Cancer: From Pathogenesis to Multidisciplinary Management
2024
·
Angioletta Lasagna
, Paolo Sacchi
·
Cancers
·
18
PDF
How to Use Prophylactic G-CSF in the Time of COVID-19
2020
·
Angioletta Lasagna
, Valentina Zuccaro
, et al.
·
JCO Oncology Practice
·
18
Use of Sorafenib in Two Metastatic Renal Cell Cancer Patients with End-Stage Renal Impairment Undergoing Replacement Hemodialysis
2009
·
Elisa Ferraris
, Pamela Di Cesare
, et al.
·
Tumori Journal
·
18
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium
2024
·
M.V. Lenti
, D.G. Ribaldone
, et al.
·
ESMO Open
·
16
PDF
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology
2023
·
Angioletta Lasagna
, Antonella Brunello
, et al.
·
Tumori Journal
·
16
PDF
G-CSF and G-CSF-Related Vasculitis: A Systematic Review of the Literature and Intriguing Future Research Perspectives
2021
·
Marta Muzzana
, Paolo Pedrazzoli
, et al.
·
Future Oncology
·
15
Show more works
View as search
Works count:
89
Citation count:
992
H-index:
19
I10-index:
35
Year
Topic
Type